{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-004316","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2023-01-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.612721+00:00","generated_at":"2026-06-20T14:42:18.899895+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"VYNE redeems all Series A Preferred Stock for $360K, eliminates series designation","bullets":["Redeemed all outstanding Series A Convertible Preferred Stock for $360,000 (120% of stated value) on Jan 17, 2023.","Filed Certificate of Elimination removing designation of 3,000 Series A shares with Delaware Secretary of State.","Eliminated shares resume status as authorized but unissued and non-designated preferred stock.","No outstanding Series A shares remain after redemption; sole holder received full payment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-004316","json":"https://secwatch.observer/filing/0001104659-23-004316.json","markdown":"https://secwatch.observer/filing/0001104659-23-004316.md","text":"https://secwatch.observer/filing/0001104659-23-004316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465923004316/0001104659-23-004316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465923004316/tm233612d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T14:42:18.899895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ee6f57e0ca268a32bc1e4f398f10f72bae5bb123","claim":"VYNE Therapeutics Inc.: Filed a Certificate of Elimination to remove the designation of Series A Convertible Preferred Stock from the Amended and Restated Certificate of Incorporation, making those shares authorized but unissued preferred stock (effective 2023-01-17).","evidence_excerpt":"On January 17, 2023, the Company filed a Certificate of Elimination (the “Certificate”) with the Secretary of State of the State of Delaware with respect to the Series A Preferred Stock. The Certificate (i) eliminated the previous designation of 3,000 shares of Series A Preferred Stock from the Company’s Amended and Restated Certificate of Incorporation, none of which were outstanding at the time of filing, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of preferred stock.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465923004316/0001104659-23-004316-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-01-17"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}